---
title: "Lunai Bioworks (RENB.US) — 公司概况"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/RENB.US/overview.md"
symbol: "RENB.US"
name: "Lunai Bioworks"
parent: "https://longbridge.com/zh-CN/quote/RENB.US.md"
datetime: "2026-04-05T12:51:44.843Z"
locales:
  - [en](https://longbridge.com/en/quote/RENB.US/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RENB.US/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RENB.US/overview.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/RENB.US/overview.md) | [繁體中文](https://longbridge.com/zh-HK/quote/RENB.US/overview.md)


# Lunai Bioworks (RENB.US) — 公司概况

## 基本信息

| 项目 | 详情 |
|------|--------|
| 行业 | Biotechnology |
| 交易所 | US Market |

## 公司简介

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands. It operates through two segments, RENB and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients.


---

> **免责声明: 本文仅供参考，不构成任何投资建议。**